BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, December 19, 2025
Home » Authors » Sergio Held

Articles by Sergio Held

Conspirators have still not been named: Brazil investigates med-tech cartel, companies could face massive fines

Dec. 17, 2015
By Sergio Held

Sanofi Pasteur dengue vaccine gets world-first approval in Mexico

Dec. 11, 2015
By Sergio Held
BOGOTA, Colombia – Mexico became the first country in the world this week to approve a Sanofi Pasteur vaccine for dengue, a product that has been in development for two decades.
Read More

Program to promote awareness of the disease: Boston Scientific expands fight against Chagas in LatAm; ICDs behind the strategy

Dec. 9, 2015
By Sergio Held

How High is the Maximum?: Colombia's med-tech price caps under scrutiny

Dec. 7, 2015
By Sergio Held

Third pathway, price caps lead Sanofi's concerns in Colombia

Dec. 7, 2015
By Sergio Held
BOGOTA, Colombia – With a dengue vaccine on the way and double-digit growth this year, multinational pharmaceutical firm Sanofi SA has high expectations for its future in Colombia.
Read More

Colombia defining technological device evaluation guidelines

Nov. 16, 2015
By Sergio Held

Pharma companies fined in Colombia for breaching price caps

Nov. 9, 2015
By Sergio Held
BOGOTA, Colombia – Regulators in Colombia have fined six pharmaceutical companies for breaching price caps set by the National Board of Prices of Drugs. Among the companies targeted are Novartis AG and Sanofi-Aventis.
Read More

Soap opera continues for company: Brazilian silicone implant nightmare having major impact on Sientra shares

Nov. 4, 2015
By Sergio Held

BIO Latin America 2015: Brazil's ability to grow biotech sector hindered by Latin American government

Oct. 22, 2015
By Sergio Held

Brazil’s ability to grow biotech sector is hindered by government

Oct. 22, 2015
By Sergio Held
RIO DE JANEIRO – Difficulties carrying out clinical trials in Brazil may be hurting the development of the biotech sector in Latin American countries, particularly Brazil.
Read More
Previous 1 2 … 14 15 16 17 18 19 20 21 22 … 31 32 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 19, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 19, 2025.
  • Acute myeloid leukemia illustration

    Apollo’s APL-4098 shows potent antileukemic effects

    BioWorld Science
    Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
  • Illustration of brain with electrical activity background

    ABS-1230 controls seizures in KCNT1-driven severe epilepsy

    BioWorld Science
    Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
  • Platelets and red blood cells

    ASH 2025: Ianalumab data offer break from chronic ITP therapy

    BioWorld
    Novartis AG’s monoclonal antibody, ianalumab (VAY-736), when added to standard-of-care eltrombopag, extended disease control of primary immune thrombocytopenia...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing